Assessing hand acceleration time before and after arteriovenous fistula creation
Hand Acceleration Time (HAT) Assessment of the Hand's Arterial Perfusion Before and After Creating an Arteriovenous Fistula (AVF) for Dialysis: A Prospective Cohort Study
This study is testing how hand movement changes before and after creating a special access point for hemodialysis to see if it affects blood flow and any related problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 125 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital Universitari de Bellvitge Academic / other |
| Locations | 1 site (L'Hospitalet De Llobregat, Barcelona) |
| Trial ID | NCT06187207 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare hand acceleration time (HAT) measurements before and after the creation of an arteriovenous fistula (AVF) for hemodialysis. It will assess the relationship between HAT and the incidence of hemodialysis access-induced distal ischemia (HAIDI). Additionally, the study will evaluate the incidence of HAIDI in patients who underwent AVF creation in the last six months, as well as the permeability and complications of the AVF at six months post-procedure. The study utilizes non-invasive diagnostic methods, including duplex ultrasound, to gather relevant data.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients aged 18 and older who are candidates for arteriovenous fistula creation for hemodialysis.
Not a fit: Patients who are unable to understand or comply with study-related procedures or who refuse to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of hemodialysis access-induced distal ischemia, potentially enhancing patient outcomes.
How similar studies have performed: While the specific approach of measuring hand acceleration time in this context may be novel, similar studies have explored the incidence of HAIDI and its implications in AVF patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥18 years of age) * Both sexes * Candidates for AVF creation for hemodialysis * Patients who sign the informed consent form Exclusion Criteria: * Patients deemed unable by the investigators to understand or comply with study-related procedures * Patients who refuse to participate in the study
Where this trial is running
L'Hospitalet De Llobregat, Barcelona
- Hospital Universitari de Bellvitge — L'Hospitalet De Llobregat, Barcelona, Spain (Recruiting)
Study contacts
- Principal investigator: Begoña Gonzalo, MD — Hospital Universitari de Bellvitge
- Study coordinator: Begoña Gonzalo, MD
- Email: bgonzalo@bellvitgehospital.cat
- Phone: +34932607323
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.